慢性呼吸疾病肺康复护理专家共识

2020-05-30 中华护理杂志.2020.55(5):1-8.

《共识》融合了19名临床护理专家的建议,结果具有科学性、严谨性和权威性。该《共识》不仅能够为临床护理实践提供指引,还为该领域指南、标准的制订奠定了基础,但仍需要进一步的理论和实证研究验证。

中文标题:

慢性呼吸疾病肺康复护理专家共识

发布机构:

发布日期:

2020-05-30

简要介绍:

《共识》融合了19名临床护理专家的建议,结果具有科学性、严谨性和权威性。该《共识》不仅能够为临床护理实践提供指引,还为该领域指南、标准的制订奠定了基础,但仍需要进一步的理论和实证研究验证。

相关资料下载:
[AttachmentFileName(sort=1, fileName=慢性呼吸疾病肺康复护理专家共识_宫玉翠.pdf)] GetToolGuiderByIdResponse(projectId=1, id=589c01c0019a2852, title=慢性呼吸疾病肺康复护理专家共识, enTitle=, guiderFrom=中华护理杂志.2020.55(5):1-8., authorId=0, author=, summary=《共识》融合了19名临床护理专家的建议,结果具有科学性、严谨性和权威性。该《共识》不仅能够为临床护理实践提供指引,还为该领域指南、标准的制订奠定了基础,但仍需要进一步的理论和实证研究验证。, cover=https://img.medsci.cn/2020731/1596199940823_2020535.jpg, journalId=0, articlesId=null, associationId=0, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Sat May 30 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<p style="color: #373737;">《共识》融合了19名临床护理专家的建议,结果具有科学性、严谨性和权威性。该《共识》不仅能够为临床护理实践提供指引,还为该领域指南、标准的制订奠定了基础,但仍需要进一步的理论和实证研究验证。</p>, tagList=[], categoryList=[CategoryDto(categoryId=12, categoryName=呼吸, tenant=100), CategoryDto(categoryId=79, categoryName=护理, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=43567, articleKeyword=呼吸疾病, articleKeywordNum=6, guiderKeywordId=43567, guiderKeyword=呼吸疾病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=5, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7627, appHits=775, showAppHits=0, pcHits=1962, showPcHits=6852, likes=5, shares=41, comments=44, approvalStatus=1, publishedTime=Fri Jul 31 21:09:09 CST 2020, publishedTimeString=2020-05-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Fri Jul 31 20:52:33 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 10:13:31 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=慢性呼吸疾病肺康复护理专家共识_宫玉翠.pdf)])
慢性呼吸疾病肺康复护理专家共识_宫玉翠.pdf
下载请点击:
评论区 (34)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2094062, encodeId=6e0f2094062e9, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=287b8377358, createdName=ms6000002058072235, createdTime=Sun Oct 16 15:18:02 CST 2022, time=2022-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084083, encodeId=6d4210840834f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0544717339, createdName=htt260261, createdTime=Fri Dec 24 23:04:05 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077940, encodeId=accd10e794021, content=及时应用于临床, beContent=null, objectType=guider, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eff45412339, createdName=ms8000000108399977, createdTime=Wed Dec 08 06:32:31 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074020, encodeId=2fc710e40201a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08415729146, createdName=ms6000001694589922, createdTime=Thu Nov 25 23:34:14 CST 2021, time=2021-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073102, encodeId=b3cb10e310231, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bb45503203, createdName=习习123, createdTime=Tue Nov 23 09:19:03 CST 2021, time=2021-11-23, status=1, ipAttribution=)]
    2022-10-16 ms6000002058072235

    值得学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2094062, encodeId=6e0f2094062e9, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=287b8377358, createdName=ms6000002058072235, createdTime=Sun Oct 16 15:18:02 CST 2022, time=2022-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084083, encodeId=6d4210840834f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0544717339, createdName=htt260261, createdTime=Fri Dec 24 23:04:05 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077940, encodeId=accd10e794021, content=及时应用于临床, beContent=null, objectType=guider, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eff45412339, createdName=ms8000000108399977, createdTime=Wed Dec 08 06:32:31 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074020, encodeId=2fc710e40201a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08415729146, createdName=ms6000001694589922, createdTime=Thu Nov 25 23:34:14 CST 2021, time=2021-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073102, encodeId=b3cb10e310231, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bb45503203, createdName=习习123, createdTime=Tue Nov 23 09:19:03 CST 2021, time=2021-11-23, status=1, ipAttribution=)]
    2021-12-24 htt260261

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2094062, encodeId=6e0f2094062e9, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=287b8377358, createdName=ms6000002058072235, createdTime=Sun Oct 16 15:18:02 CST 2022, time=2022-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084083, encodeId=6d4210840834f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0544717339, createdName=htt260261, createdTime=Fri Dec 24 23:04:05 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077940, encodeId=accd10e794021, content=及时应用于临床, beContent=null, objectType=guider, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eff45412339, createdName=ms8000000108399977, createdTime=Wed Dec 08 06:32:31 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074020, encodeId=2fc710e40201a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08415729146, createdName=ms6000001694589922, createdTime=Thu Nov 25 23:34:14 CST 2021, time=2021-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073102, encodeId=b3cb10e310231, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bb45503203, createdName=习习123, createdTime=Tue Nov 23 09:19:03 CST 2021, time=2021-11-23, status=1, ipAttribution=)]
    2021-12-08 ms8000000108399977

    及时应用于临床

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2094062, encodeId=6e0f2094062e9, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=287b8377358, createdName=ms6000002058072235, createdTime=Sun Oct 16 15:18:02 CST 2022, time=2022-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084083, encodeId=6d4210840834f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0544717339, createdName=htt260261, createdTime=Fri Dec 24 23:04:05 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077940, encodeId=accd10e794021, content=及时应用于临床, beContent=null, objectType=guider, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eff45412339, createdName=ms8000000108399977, createdTime=Wed Dec 08 06:32:31 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074020, encodeId=2fc710e40201a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08415729146, createdName=ms6000001694589922, createdTime=Thu Nov 25 23:34:14 CST 2021, time=2021-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073102, encodeId=b3cb10e310231, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bb45503203, createdName=习习123, createdTime=Tue Nov 23 09:19:03 CST 2021, time=2021-11-23, status=1, ipAttribution=)]
    2021-11-25 ms6000001694589922

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2094062, encodeId=6e0f2094062e9, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=287b8377358, createdName=ms6000002058072235, createdTime=Sun Oct 16 15:18:02 CST 2022, time=2022-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084083, encodeId=6d4210840834f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0544717339, createdName=htt260261, createdTime=Fri Dec 24 23:04:05 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077940, encodeId=accd10e794021, content=及时应用于临床, beContent=null, objectType=guider, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eff45412339, createdName=ms8000000108399977, createdTime=Wed Dec 08 06:32:31 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074020, encodeId=2fc710e40201a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08415729146, createdName=ms6000001694589922, createdTime=Thu Nov 25 23:34:14 CST 2021, time=2021-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073102, encodeId=b3cb10e310231, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bb45503203, createdName=习习123, createdTime=Tue Nov 23 09:19:03 CST 2021, time=2021-11-23, status=1, ipAttribution=)]
    2021-11-23 习习123

    学习

    0

拓展阅读

治世能臣还是乱世枭雄:浅谈巨噬细胞的双面人生

组织浸润的单核巨噬细胞分化为单核来源的巨噬细胞,但其分化环境是在疾病状态下,和原始“土著”巨噬细胞成长环境大相径庭。因此,它们往往成为了推动疾病进展的“罪魁祸首”。

Lancet Global Health:清洁烹饪燃料可降低心肺死亡风险

研究认为,烹饪使用固体燃料与较高的死亡风险有关,停止使用固体燃料可迅速大幅度降低死亡率。通风的使用也显著降低了死亡风险

Eur Heart J:空气污染导致每年全球880万人死亡,因心血管病死亡是呼吸疾病的两倍

根据发表在《欧洲心脏杂志》上的一项研究,2015年,空气污染(PM2.5和臭氧)在整个欧洲造成了79万人死亡,在这些死亡中,40%~80%死于心血管疾病。

浙大一院周建英教授:远程医疗在基层呼吸疾病防治中扮演重要角色

在我国,慢病总体死亡率呈上升趋势。常见的四大慢病包括心脑血管病、慢性呼吸系统疾病、糖尿病和肿瘤。其中心脑血管病、糖尿病的规范诊断与治疗已经在基层普及,而慢性呼吸系统疾病的基层诊疗直到最近几年才逐步推进。

J Occup Environ Med:化学和建筑相关不耐受气道炎症性疾病的并发症分析

最近,有研究人员调查了慢性鼻窦炎、慢性阻塞性肺病、过敏和非过敏哮喘和过敏性鼻炎以及气道炎症症状中的化学不耐受(CI)和建筑相关的不耐受(BRI)并发症。研究人员从2个基于群体的环江健康研究调查问卷中搜集了相关数据。参与者被分成CI或者BRI组和参照组,并且还利用了二维的逻辑回归分析进行了数据分析。研究发现,案例组的疾病患病率为7.2%-40.0%,症状患病率为24.3%-68.9%,调整后的疾病让

Thorax:长期使用阿片类药物竟会增加呼吸疾病的死亡率!

2017年11月,发表在《Thorax》上的一项队列研究,调查了阿片类药物的使用相关与呼吸疾病死亡率之间的关系。